| Mechanisms of ischemic brain injury | 2004/03/01 | English | 92 |
| 18F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis | 2013/03/16 | English | 90 |
| Cardiovascular Disease and Hair Cortisol: a Novel Biomarker of Chronic Stress | 2019/08/30 | English | 90 |
| Dyslipidemia of the metabolic syndrome | 2002/11/01 | English | 88 |
| Vasodilatory edema: A common side effect of antihypertensive therapy | 2002/11/01 | English | 85 |
| Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure | 2019/06/21 | English | 84 |
| Migraine and the Risk for Stroke and Cardiovascular Disease | 2014/07/25 | English | 84 |
| Dyslipidemias in the Prevention of Cardiovascular Disease: Risks and Causality | 2012/09/11 | English | 83 |
| Infective Endocarditis: Update on Epidemiology, Outcomes, and Management | 2018/08/16 | English | 82 |
| Diabetes and Associated Complications in the South Asian Population | 2014/03/20 | English | 81 |
| Cardiac Tumors: Diagnosis, Prognosis, and Treatment | 2020/10/10 | English | 79 |
| Anxiety and Cardiovascular Disease Risk: a Review | 2016/10/31 | English | 79 |
| Myocardial Extracellular Volume Quantification by Cardiovascular Magnetic Resonance and Computed Tomography | 2018/03/01 | English | 79 |
| The Role of Anticoagulation in COVID-19-Induced Hypercoagulability | 2020/06/17 | English | 78 |
| Hypertension in Obesity and the Impact of Weight Loss | 2017/08/24 | English | 78 |
| Mindfulness and Cardiovascular Disease Risk: State of the Evidence, Plausible Mechanisms, and Theoretical Framework | 2015/10/19 | English | 76 |
| Natriuretic peptides in the pathophysiology of congestive heart failure | 2000/05/01 | English | 76 |
| HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics | 2017/11/04 | English | 74 |
| Failing energetics in failing hearts | 2000/05/01 | English | 72 |
| Psychosocial Factors in Diabetes and Cardiovascular Risk | 2016/08/27 | English | 72 |
| Coarctation of the aorta | 2005/11/01 | English | 71 |
| Genetic Architecture of Familial Hypercholesterolaemia | 2017/04/13 | English | 71 |
| Does Aggressive Glycemic Control Benefit Macrovascular and Microvascular Disease in Type 2 Diabetes?: Insights from ACCORD, ADVANCE, and VADT | 2011/12/13 | English | 70 |
| Hypothyroidism and dyslipidemia: Modern concepts and approaches | 2004/11/01 | English | 68 |
| Far from the Eyes, Close to the Heart: Dysbiosis of Gut Microbiota and Cardiovascular Consequences | 2014/10/11 | English | 68 |
| Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy? | 2016/05/23 | English | 68 |
| Myocarditis: A Clinical Overview | 2017/05/25 | English | 68 |
| Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes | 2019/04/22 | English | 67 |
| Acute and Fulminant Myocarditis: a Pragmatic Clinical Approach to Diagnosis and Treatment | 2018/09/26 | English | 67 |
| Targeted PET/CT Imaging of Vulnerable Atherosclerotic Plaques: Microcalcification with Sodium Fluoride and Inflammation with Fluorodeoxyglucose | 2013/04/19 | English | 65 |